{
    "Rank": 750,
    "Study": {
        "ProtocolSection": {
            "IdentificationModule": {
                "NCTId": "NCT03390608",
                "OrgStudyIdInfo": {
                    "OrgStudyId": "365"
                },
                "Organization": {
                    "OrgFullName": "Karolinska Institutet",
                    "OrgClass": "OTHER"
                },
                "BriefTitle": "Prognostic and Predictive Factors for Small Breast Tumors",
                "OfficialTitle": "Prognosis, Prognostic Factors and Predictive Factors in Centimeter or Subcentimeter Node-negative Breast Cancer"
            },
            "StatusModule": {
                "StatusVerifiedDate": "December 2017",
                "OverallStatus": "Completed",
                "ExpandedAccessInfo": {
                    "HasExpandedAccess": "No"
                },
                "StartDateStruct": {
                    "StartDate": "January 1, 1977",
                    "StartDateType": "Actual"
                },
                "PrimaryCompletionDateStruct": {
                    "PrimaryCompletionDate": "December 31, 2014",
                    "PrimaryCompletionDateType": "Actual"
                },
                "CompletionDateStruct": {
                    "CompletionDate": "July 30, 2016",
                    "CompletionDateType": "Actual"
                },
                "StudyFirstSubmitDate": "December 15, 2017",
                "StudyFirstSubmitQCDate": "December 28, 2017",
                "StudyFirstPostDateStruct": {
                    "StudyFirstPostDate": "January 4, 2018",
                    "StudyFirstPostDateType": "Actual"
                },
                "LastUpdateSubmitDate": "December 28, 2017",
                "LastUpdatePostDateStruct": {
                    "LastUpdatePostDate": "January 4, 2018",
                    "LastUpdatePostDateType": "Actual"
                }
            },
            "SponsorCollaboratorsModule": {
                "ResponsibleParty": {
                    "ResponsiblePartyType": "Principal Investigator",
                    "ResponsiblePartyInvestigatorFullName": "Andreas Pettersson",
                    "ResponsiblePartyInvestigatorTitle": "Researcher, Principal Investigator",
                    "ResponsiblePartyInvestigatorAffiliation": "Karolinska Institutet"
                },
                "LeadSponsor": {
                    "LeadSponsorName": "Karolinska Institutet",
                    "LeadSponsorClass": "OTHER"
                },
                "CollaboratorList": {
                    "Collaborator": [
                        {
                            "CollaboratorName": "The Swedish Society of Medicine",
                            "CollaboratorClass": "OTHER"
                        },
                        {
                            "CollaboratorName": "The Swedish Breast Cancer Association (BRO)",
                            "CollaboratorClass": "UNKNOWN"
                        },
                        {
                            "CollaboratorName": "Swedish Breast Cancer Group",
                            "CollaboratorClass": "OTHER"
                        }
                    ]
                }
            },
            "OversightModule": {
                "OversightHasDMC": "No",
                "IsFDARegulatedDrug": "No",
                "IsFDARegulatedDevice": "No"
            },
            "DescriptionModule": {
                "BriefSummary": "Because of mammography screening increasingly more women are diagnosed with centimeter or subcentimeter node-negative breast cancer (i.e., T1abN0); these tumors account for approximately 19% of all newly diagnosed breast cancers in Sweden. Although the long term relapse-free survival rates among patients with such tumors is as high as \u226590%, some reports suggest that certain patient subgroups may have rates <75%. Firmly established prognostic and predictive factors for patients with T1abN0 tumors are, however, lacking. This is a nationwide, register-based cohort study investigating prognostic and predictive factors in women with centimeter or subcentimeter breast cancer. The study hypotheses are: 1) Established prognostic and/or predictive factors in overall breast cancer are prognostic and/or predictive factors also in centimeter or subcentimeter node-negative breast cancer; 2) The established relative reduction in risk of recurrence and death of adjuvant treatment for overall breast cancer are similar in centimeter or subcentimeter node-negative breast cancer."
            },
            "ConditionsModule": {
                "ConditionList": {
                    "Condition": [
                        "Breast Cancer"
                    ]
                }
            },
            "DesignModule": {
                "StudyType": "Observational",
                "PatientRegistry": "No",
                "DesignInfo": {
                    "DesignObservationalModelList": {
                        "DesignObservationalModel": [
                            "Cohort"
                        ]
                    },
                    "DesignTimePerspectiveList": {
                        "DesignTimePerspective": [
                            "Retrospective"
                        ]
                    }
                },
                "EnrollmentInfo": {
                    "EnrollmentCount": "35002",
                    "EnrollmentType": "Actual"
                }
            },
            "ArmsInterventionsModule": {
                "ArmGroupList": {
                    "ArmGroup": [
                        {
                            "ArmGroupLabel": "Women with T1ab breast cancer.",
                            "ArmGroupInterventionList": {
                                "ArmGroupInterventionName": [
                                    "Drug: Endocrine therapy",
                                    "Radiation: Radiotherapy",
                                    "Drug: Herceptin",
                                    "Drug: Chemotherapy",
                                    "Procedure: Type of breast cancer surgery",
                                    "Other: Age at diagnosis",
                                    "Other: Screen detected tumor",
                                    "Other: Menopausal status at diagnosis",
                                    "Other: Tumor size",
                                    "Other: Estrogen receptor (ER) status",
                                    "Other: Tumor grade",
                                    "Other: HER2-status",
                                    "Other: Intrinsic subgroups of breast cancer",
                                    "Other: Nodal status"
                                ]
                            }
                        }
                    ]
                },
                "InterventionList": {
                    "Intervention": [
                        {
                            "InterventionType": "Drug",
                            "InterventionName": "Endocrine therapy",
                            "InterventionDescription": "Endocrine treatment versus no endocrine therapy (in women with hormone receptor positive1 disease).",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Women with T1ab breast cancer."
                                ]
                            }
                        },
                        {
                            "InterventionType": "Radiation",
                            "InterventionName": "Radiotherapy",
                            "InterventionDescription": "Radiotherapy versus no radiotherapy.",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Women with T1ab breast cancer."
                                ]
                            }
                        },
                        {
                            "InterventionType": "Drug",
                            "InterventionName": "Herceptin",
                            "InterventionDescription": "Trastuzumab versus no trastuzumab (in women with HER2-positive disease).",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Women with T1ab breast cancer."
                                ]
                            }
                        },
                        {
                            "InterventionType": "Drug",
                            "InterventionName": "Chemotherapy",
                            "InterventionDescription": "Chemotherapy versus no chemotherapy.",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Women with T1ab breast cancer."
                                ]
                            }
                        },
                        {
                            "InterventionType": "Procedure",
                            "InterventionName": "Type of breast cancer surgery",
                            "InterventionDescription": "Type of surgery (partial mastectomy, mastectomy, other).",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Women with T1ab breast cancer."
                                ]
                            }
                        },
                        {
                            "InterventionType": "Other",
                            "InterventionName": "Age at diagnosis",
                            "InterventionDescription": "Age at diagnosis (<35, 35-<50, 50-<70, \u226570).",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Women with T1ab breast cancer."
                                ]
                            }
                        },
                        {
                            "InterventionType": "Other",
                            "InterventionName": "Screen detected tumor",
                            "InterventionDescription": "Screening detected tumor (yes, no).",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Women with T1ab breast cancer."
                                ]
                            }
                        },
                        {
                            "InterventionType": "Other",
                            "InterventionName": "Menopausal status at diagnosis",
                            "InterventionDescription": "Menopausal status (premenopausal, postmenopausal).",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Women with T1ab breast cancer."
                                ]
                            }
                        },
                        {
                            "InterventionType": "Other",
                            "InterventionName": "Tumor size",
                            "InterventionDescription": "Tumor size (\u22645 mm, 6-\u226410 mm).",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Women with T1ab breast cancer."
                                ]
                            }
                        },
                        {
                            "InterventionType": "Other",
                            "InterventionName": "Estrogen receptor (ER) status",
                            "InterventionDescription": "ER-status (positive, negative).",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Women with T1ab breast cancer."
                                ]
                            }
                        },
                        {
                            "InterventionType": "Other",
                            "InterventionName": "Tumor grade",
                            "InterventionDescription": "Tumor grade (1, 2, 3).",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Women with T1ab breast cancer."
                                ]
                            }
                        },
                        {
                            "InterventionType": "Other",
                            "InterventionName": "HER2-status",
                            "InterventionDescription": "HER2-status (positive, negative).",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Women with T1ab breast cancer."
                                ]
                            }
                        },
                        {
                            "InterventionType": "Other",
                            "InterventionName": "Intrinsic subgroups of breast cancer",
                            "InterventionDescription": "Intrinsic subgroup proxy (Luminal A, Luminal B (HER2-negative), Luminal B (HER2-positive), HER2-positive (non-luminal), Triple negative).",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Women with T1ab breast cancer."
                                ]
                            }
                        },
                        {
                            "InterventionType": "Other",
                            "InterventionName": "Nodal status",
                            "InterventionDescription": "N-status (N0, N1).",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Women with T1ab breast cancer."
                                ]
                            }
                        }
                    ]
                }
            },
            "OutcomesModule": {
                "PrimaryOutcomeList": {
                    "PrimaryOutcome": [
                        {
                            "PrimaryOutcomeMeasure": "Breast cancer specific death",
                            "PrimaryOutcomeTimeFrame": "January 1, 1977 to December 31, 2014"
                        }
                    ]
                },
                "SecondaryOutcomeList": {
                    "SecondaryOutcome": [
                        {
                            "SecondaryOutcomeMeasure": "Death from any cause",
                            "SecondaryOutcomeTimeFrame": "January 1, 1977 to July 30, 2016"
                        },
                        {
                            "SecondaryOutcomeMeasure": "Metachronous breast cancer",
                            "SecondaryOutcomeDescription": "Ipsilateral or contralateral breast cancer",
                            "SecondaryOutcomeTimeFrame": "January 1, 1977 to July 30, 2016"
                        }
                    ]
                }
            },
            "EligibilityModule": {
                "EligibilityCriteria": "Inclusion Criteria:\n\nFemale.\nOperated for centimeter or subcentimeter breast cancer.\n\nExclusion Criteria:\n\nPrevious breast cancer.\nMetastatic breast cancer at diagnosis.",
                "Gender": "Female",
                "GenderBased": "Yes",
                "MaximumAge": "100 Years",
                "StdAgeList": {
                    "StdAge": [
                        "Child",
                        "Adult",
                        "Older Adult"
                    ]
                },
                "StudyPopulation": "The study population consists of all Swedish women operated for centimeter or subcentimeter breast cancer who are included in the regional breast cancer registries (1977 to 2007) or the national breast cancer registry (2008 onwards).",
                "SamplingMethod": "Non-Probability Sample"
            },
            "ContactsLocationsModule": {
                "LocationList": {
                    "Location": [
                        {
                            "LocationFacility": "Karolinska Instiutet",
                            "LocationCity": "Solna",
                            "LocationZip": "17177",
                            "LocationCountry": "Sweden"
                        }
                    ]
                }
            },
            "IPDSharingStatementModule": {
                "IPDSharing": "No"
            }
        },
        "DocumentSection": {
            "LargeDocumentModule": {
                "LargeDocList": {
                    "LargeDoc": [
                        {
                            "LargeDocTypeAbbrev": "SAP",
                            "LargeDocHasProtocol": "No",
                            "LargeDocHasSAP": "Yes",
                            "LargeDocHasICF": "No",
                            "LargeDocLabel": "Statistical Analysis Plan",
                            "LargeDocDate": "November 10, 2017",
                            "LargeDocUploadDate": "12/15/2017 15:56",
                            "LargeDocFilename": "SAP_000.pdf"
                        },
                        {
                            "LargeDocTypeAbbrev": "Prot",
                            "LargeDocHasProtocol": "Yes",
                            "LargeDocHasSAP": "No",
                            "LargeDocHasICF": "No",
                            "LargeDocLabel": "Study Protocol",
                            "LargeDocDate": "February 22, 2014",
                            "LargeDocUploadDate": "12/28/2017 08:02",
                            "LargeDocFilename": "Prot_001.pdf"
                        }
                    ]
                }
            }
        },
        "DerivedSection": {
            "MiscInfoModule": {
                "VersionHolder": "September 08, 2023"
            },
            "ConditionBrowseModule": {
                "ConditionMeshList": {
                    "ConditionMesh": [
                        {
                            "ConditionMeshId": "D000001943",
                            "ConditionMeshTerm": "Breast Neoplasms"
                        }
                    ]
                },
                "ConditionAncestorList": {
                    "ConditionAncestor": [
                        {
                            "ConditionAncestorId": "D000009371",
                            "ConditionAncestorTerm": "Neoplasms by Site"
                        },
                        {
                            "ConditionAncestorId": "D000009369",
                            "ConditionAncestorTerm": "Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000001941",
                            "ConditionAncestorTerm": "Breast Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000012871",
                            "ConditionAncestorTerm": "Skin Diseases"
                        }
                    ]
                },
                "ConditionBrowseLeafList": {
                    "ConditionBrowseLeaf": [
                        {
                            "ConditionBrowseLeafId": "M4910",
                            "ConditionBrowseLeafName": "Breast Neoplasms",
                            "ConditionBrowseLeafAsFound": "Breast Cancer",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M4908",
                            "ConditionBrowseLeafName": "Breast Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M15364",
                            "ConditionBrowseLeafName": "Skin Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        }
                    ]
                },
                "ConditionBrowseBranchList": {
                    "ConditionBrowseBranch": [
                        {
                            "ConditionBrowseBranchAbbrev": "BC04",
                            "ConditionBrowseBranchName": "Neoplasms"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "BC17",
                            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "All",
                            "ConditionBrowseBranchName": "All Conditions"
                        }
                    ]
                }
            },
            "InterventionBrowseModule": {
                "InterventionMeshList": {
                    "InterventionMesh": [
                        {
                            "InterventionMeshId": "D000068878",
                            "InterventionMeshTerm": "Trastuzumab"
                        },
                        {
                            "InterventionMeshId": "D000004967",
                            "InterventionMeshTerm": "Estrogens"
                        }
                    ]
                },
                "InterventionAncestorList": {
                    "InterventionAncestor": [
                        {
                            "InterventionAncestorId": "D000074322",
                            "InterventionAncestorTerm": "Antineoplastic Agents, Immunological"
                        },
                        {
                            "InterventionAncestorId": "D000000970",
                            "InterventionAncestorTerm": "Antineoplastic Agents"
                        },
                        {
                            "InterventionAncestorId": "D000006728",
                            "InterventionAncestorTerm": "Hormones"
                        },
                        {
                            "InterventionAncestorId": "D000006730",
                            "InterventionAncestorTerm": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                        },
                        {
                            "InterventionAncestorId": "D000045505",
                            "InterventionAncestorTerm": "Physiological Effects of Drugs"
                        }
                    ]
                },
                "InterventionBrowseLeafList": {
                    "InterventionBrowseLeaf": [
                        {
                            "InterventionBrowseLeafId": "M325",
                            "InterventionBrowseLeafName": "Trastuzumab",
                            "InterventionBrowseLeafAsFound": "COPD",
                            "InterventionBrowseLeafRelevance": "high"
                        },
                        {
                            "InterventionBrowseLeafId": "M9479",
                            "InterventionBrowseLeafName": "Hormones",
                            "InterventionBrowseLeafRelevance": "low"
                        },
                        {
                            "InterventionBrowseLeafId": "M7806",
                            "InterventionBrowseLeafName": "Estrogens",
                            "InterventionBrowseLeafAsFound": "Postoperative Pain",
                            "InterventionBrowseLeafRelevance": "high"
                        },
                        {
                            "InterventionBrowseLeafId": "M1346",
                            "InterventionBrowseLeafName": "Antineoplastic Agents, Immunological",
                            "InterventionBrowseLeafRelevance": "low"
                        },
                        {
                            "InterventionBrowseLeafId": "M9478",
                            "InterventionBrowseLeafName": "Hormone Antagonists",
                            "InterventionBrowseLeafRelevance": "low"
                        }
                    ]
                },
                "InterventionBrowseBranchList": {
                    "InterventionBrowseBranch": [
                        {
                            "InterventionBrowseBranchAbbrev": "ANeo",
                            "InterventionBrowseBranchName": "Antineoplastic Agents"
                        },
                        {
                            "InterventionBrowseBranchAbbrev": "All",
                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                        }
                    ]
                }
            }
        }
    }
}